Table 4.
Secondary causes of osteoporosis.
| Endocrine disorders | Acromegaly |
| Diabetes mellitus (type 1 and type 2) | |
| Growth hormone deficiency | |
| Hypercortisolism | |
| Hyperparathyroidism | |
| Hyperthyroidism | |
| Hypogonadism | |
| Rheumatological disorders | Rheumatoid arthritis |
| Ankylosing spondylitis | |
| Systemic lupus erythematosus | |
| Haematological disorders | Multiple myeloma |
| Monoclonal gammopathy of undetermined significance | |
| Beta thalassemia major | |
| Systemic mastocytosis | |
| Gastrointestinal disorders | Chronic liver disease |
| Inflammatory bowel disease | |
| Primary biliary cirrhosis | |
| Malabsorption syndrome | |
| Post gastric bypass surgery | |
| Neurological disorders | Epilepsy |
| Parkinsonism | |
| Stroke | |
| Nephrological disorders | Idiopathic hypercalciuria |
| Chronic kidney disease | |
| Renal tubular acidosis | |
| Other medical conditions | Acquired immunodeficiency syndrome |
| Chronic obstructive pulmonary disease | |
| Post-transplantation | |
| Malnutrition | |
| Genetic disorders | Osteogenesis imperfecta |
| Marfan's syndrome | |
| Ehlers-Danlos syndrome | |
| Medications | Anti-epileptic drugs |
| Aromatase inhibitors | |
| Anticoagulant (heparin, warfarin) | |
| Immunosuppressant (cyclosporine A, tacrolimus) | |
| Glucocorticoids | |
| Gonadotropin-releasing hormone agonist | |
| Medroxyprogesterone acetate | |
| Pioglitazone | |
| Proton pump inhibitor | |
| Selective serotonin-reuptake inhibitor |